M28 Capital Management’s NexImmune, Inc. Common Stock NEXI Stock Holding History

M28 Capital Management’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,338	Closed	-$28K	–	11
2023 Q3	$28K	Hold	5,338	–	–	0.03%	11
2023 Q2	$37.6K	Hold	5,338	–	–	0.05%	12
2023 Q1	$50.7K	Hold	5,338	–	–	0.06%	14
2022 Q4	$32.4K	Hold	5,338	–	–	0.03%	14
2022 Q3	$74K	Hold	5,338	–	–	0.08%	12
2022 Q2	$215K	Hold	5,338	–	–	0.24%	13
2022 Q1	$562K	Hold	5,338	–	–	0.52%	13
2021 Q4	$615K	Buy	+5,338	New	+$1.28M	0.48%	12

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

M28 Capital Management's NEXI Position: Q4 2023 in Review

M28 Capital Management sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 5,338 shares — an estimated $28K sold.

M28 Capital Management first reported a position in NEXI in Q4 2021 and held it in 8 quarters. The position peaked at $615K in Q4 2021. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

M28 Capital Management reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
M28 Capital Management sold 5,338 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $28K.
M28 Capital Management first reported a position in NexImmune, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
M28 Capital Management's NexImmune, Inc. Common Stock position peaked at $615K in Q4 2021.
11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on M28 Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.